These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9600772)

  • 1. Potential role of rhIGF-I/IGFBP-3 in maintaining skeletal mass in space.
    Tanaka H; Moriwake T; Matsuoka Y; Nakamura T; Seino Y
    Bone; 1998 May; 22(5 Suppl):145S-147S. PubMed ID: 9600772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary protein restriction lowers plasma insulin-like growth factor I (IGF-I), impairs cortical bone formation, and induces osteoblastic resistance to IGF-I in adult female rats.
    Bourrin S; Ammann P; Bonjour JP; Rizzoli R
    Endocrinology; 2000 Sep; 141(9):3149-55. PubMed ID: 10965885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.
    Narusawa K; Nakamura T; Suzuki K; Matsuoka Y; Lee LJ; Tanaka H; Seino Y
    J Bone Miner Res; 1995 Dec; 10(12):1853-64. PubMed ID: 8619365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism.
    Miyakoshi N; Qin X; Kasukawa Y; Richman C; Srivastava AK; Baylink DJ; Mohan S
    Endocrinology; 2001 Jun; 142(6):2641-8. PubMed ID: 11356715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.
    Boonen S; Rosen C; Bouillon R; Sommer A; McKay M; Rosen D; Adams S; Broos P; Lenaerts J; Raus J; Vanderschueren D; Geusens P
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1593-9. PubMed ID: 11932288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats.
    Machwate M; Zerath E; Holy X; Pastoureau P; Marie PJ
    Endocrinology; 1994 Mar; 134(3):1031-8. PubMed ID: 8119139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F; Lang K; Dony C; Kling L
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that IGF-binding protein-5 functions as a growth factor.
    Miyakoshi N; Richman C; Kasukawa Y; Linkhart TA; Baylink DJ; Mohan S
    J Clin Invest; 2001 Jan; 107(1):73-81. PubMed ID: 11134182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-binding protein-2 and -3: their biological effects in bovine thecal cells.
    Spicer LJ; Stewart RE; Alvarez P; Francisco CC; Keefer BE
    Biol Reprod; 1997 Jun; 56(6):1458-65. PubMed ID: 9166698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study.
    Grinspoon S; Miller K; Herzog D; Clemmons D; Klibanski A
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1142-9. PubMed ID: 12629097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells.
    Lalou C; Silve C; Rosato R; Segovia B; Binoux M
    Endocrinology; 1994 Dec; 135(6):2318-26. PubMed ID: 7527330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent.
    Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S
    J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats.
    Bagi CM; DeLeon E; Brommage R; Adams S; Rosen D; Sommer A
    Bone; 1995 Apr; 16(4 Suppl):263S-269S. PubMed ID: 7542899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factors sustain insulin-like growth factor-binding protein-5 expression in osteoblasts.
    Gabbitas B; Canalis E
    Am J Physiol; 1998 Aug; 275(2):E222-8. PubMed ID: 9688622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice.
    Silha JV; Mishra S; Rosen CJ; Beamer WG; Turner RT; Powell DR; Murphy LJ
    J Bone Miner Res; 2003 Oct; 18(10):1834-41. PubMed ID: 14584894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts.
    Foulstone EJ; Savage PB; Crown AL; Holly JM; Stewart CE
    J Cell Physiol; 2003 Apr; 195(1):70-9. PubMed ID: 12599210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line.
    Gori F; Hofbauer LC; Conover CA; Khosla S
    Endocrinology; 1999 Dec; 140(12):5579-86. PubMed ID: 10579321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
    Durham SK; Kiefer MC; Riggs BL; Conover CA
    J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis?
    Schmid C; Rutishauser J; Schläpfer I; Froesch ER; Zapf J
    Biochem Biophys Res Commun; 1991 Aug; 179(1):579-85. PubMed ID: 1715698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.